XML 40 R29.htm IDEA: XBRL DOCUMENT v3.23.2
Organization and Summary of Significant Accounting Policies (Details)
6 Months Ended
Jun. 30, 2023
segment
country
product
Organization And Summary Of Significant Policies [Line Items]  
Number of countries with drug approval, excluding the u.s. | country 69
Number of business segments | segment 1
Products derived from other compounds  
Organization And Summary Of Significant Policies [Line Items]  
Number of products that entered in the commercial marketplace | product 2